{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:54:29Z","timestamp":1789016069276,"version":"build-2803163510"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Obstetric and Fetal Pharmacology Research Centers"},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD047905"],"award-info":[{"award-number":["HD047905"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Literature is divided regarding the risk of neonatal ventricular septal defect (VSD) associated with first trimester ondansetron use in pregnancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We evaluated the risk of VSD associated with first trimester exposure to intravenous or oral ondansetron in 33 677 deliveries at Magee\u2013Womens Hospital in Pittsburgh, PA (2006\u20132014). Using log-binomial regression, we evaluated the risk: (1) in the full cohort, (2) using propensity score designs with both matching and inverse probability weighting and (3) utilizing clustered trajectory analysis evaluating the role of dose. Sensitivity analyses assessed the association between ondansetron and all recorded birth defects in aggregate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 3733 (11%) pregnancies were exposed to ondansetron in the first trimester (dose range: 2.4\u20131008\u2009mg). Ondansetron was associated with increased risk of VSD with risk ratios ranging from 1.7 [95% confidence interval (CI) 1.0\u20132.9] to 2.1 (95% CI 1.1\u20134.0) across methods. Risks correspond to one additional VSD for approximately every 330 pregnancies exposed in the first trimester. The association was dose-dependent with increased risk in women receiving highest cumulative doses compared with lowest doses [adjusted risk ratio: 3.2 (95% CI 1.0\u20139.9)]. The association between ondansetron and congenital malformations was diluted as the outcome included additional birth defects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>First trimester ondansetron use is associated with an increased risk of neonatal VSD potentially driven by higher doses. This risk should be viewed in the context of risks attributable to severe untreated nausea and vomiting of pregnancy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ije\/dyz255","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T15:10:11Z","timestamp":1574176211000},"page":"648-656","source":"Crossref","is-referenced-by-count":28,"title":["Ondansetron use in the first trimester of pregnancy and the risk of neonatal ventricular septal defect"],"prefix":"10.1093","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6806-7787","authenticated-orcid":false,"given":"Lara S","family":"Lemon","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, PA, USA"},{"name":"Department of Clinical Analytics, University of Pittsburgh Medical Centers, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M","family":"Bodnar","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, PA, USA"},{"name":"Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Garrard","sequence":"first","affiliation":[{"name":"Department of Clinical Analytics, University of Pittsburgh Medical Centers, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Venkataramanan","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Science, School of Pharmacy, University of Pittsburgh, PA, USA"},{"name":"Department of Pathology, University of Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W","family":"Platt","sequence":"first","affiliation":[{"name":"Departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health, McGill University, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar C","family":"Marroquin","sequence":"first","affiliation":[{"name":"Department of Clinical Analytics, University of Pittsburgh Medical Centers, PA, USA"},{"name":"Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve N","family":"Caritis","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"key":"2020060215103152200_dyz255-B1","first-page":"CD007575","article-title":"Interventions for nausea and vomiting in early pregnancy","volume":"3","author":"Matthews","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2020060215103152200_dyz255-B2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/pds.4185","article-title":"Antiemetic use among pregnant women in the United States: the escalating use of ondansetron","volume":"26","author":"Taylor","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2020060215103152200_dyz255-B3","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1471-0528.2011.03023.x","article-title":"Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis","volume":"118","author":"Veenendaal","year":"2011","journal-title":"BJOG"},{"key":"2020060215103152200_dyz255-B4","volume-title":"StatPearls","author":"Griddine","year":"2018"},{"key":"2020060215103152200_dyz255-B5","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1471-0528.2004.00236.x","article-title":"The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study","volume":"111","author":"Einarson","year":"2004","journal-title":"BJOG"},{"key":"2020060215103152200_dyz255-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/909860","article-title":"Off-label use of ondansetron in pregnancy in Western Australia","volume":"2013","author":"Colvin","year":"2013","journal-title":"Biomed Res Int"},{"key":"2020060215103152200_dyz255-B7","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJMoa1211035","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes","volume":"368","author":"Pasternak","year":"2013","journal-title":"N Engl J Med"},{"key":"2020060215103152200_dyz255-B8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.reprotox.2014.10.017","article-title":"Use of ondansetron during pregnancy and congenital malformations in the infant","volume":"50","author":"Danielsson","year":"2014","journal-title":"Reprod Toxicol"},{"key":"2020060215103152200_dyz255-B9","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1001\/jama.2018.18307","article-title":"Association of maternal first-trimester ondansetron use with cardiac malformation and oral clefts in offspring","volume":"320","author":"Huybrechts","year":"2018","journal-title":"JAMA"},{"key":"2020060215103152200_dyz255-B10","first-page":"595","volume-title":"Pharmacoepidemiology","author":"Mitchell","year":"2012","edition":"5th edn."},{"key":"2020060215103152200_dyz255-B11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/AOG.0000000000002679","article-title":"Ondansetron for treatment of nausea and vomiting of pregnancy and the risk of specific birth defects","volume":"132","author":"Parker","year":"2018","journal-title":"Obstet Gynecol"},{"key":"2020060215103152200_dyz255-B12","first-page":"e15","article-title":"Practice Bulletin No. 189.American College of Obstetricians and Gynecologists","volume":"131","year":"2018","journal-title":"Obstet Gynecol"},{"key":"2020060215103152200_dyz255-B13","volume-title":"Zofran [Package Insert]","year":"2014"},{"key":"2020060215103152200_dyz255-B14"},{"key":"2020060215103152200_dyz255-B15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2288-8-70","article-title":"Reducing bias through directed acyclic graphs","volume":"8","author":"Shrier","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"2020060215103152200_dyz255-B16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1600-0447.2008.01194.x","article-title":"Compelling or irrelevant? Using the number needed to treat can help decide","volume":"117","author":"Citrome","year":"2008","journal-title":"Acta Psychiatr Scand"},{"key":"2020060215103152200_dyz255-B17","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/pds.968","article-title":"On principles for modeling propensity scores in medical research","volume":"13","author":"Rubin","year":"2004","journal-title":"Pharmacoepidem Drug Safe"},{"key":"2020060215103152200_dyz255-B18","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate the causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"2020060215103152200_dyz255-B19","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"2020060215103152200_dyz255-B20","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/sim.2328","article-title":"A comparison of propensity score methods: a case-study estimating the effectiveness of post-AMI statin use","volume":"25","author":"Austin","year":"2006","journal-title":"Stat Med"},{"key":"2020060215103152200_dyz255-B21","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1016\/j.cmpb.2011.05.008","article-title":"Kml: a package to cluster longitudinal data","volume":"104","author":"Genolini","year":"2011","journal-title":"Comput Methods Prog Biomed"},{"key":"2020060215103152200_dyz255-B22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/pds.4410","article-title":"Patterns of prednisone use during pregnancy in women with rheumatoid arthritis: daily and cumulative dose","volume":"27","author":"Palmsten","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2020060215103152200_dyz255-B23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.reprotox.2016.04.027","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States","volume":"62","author":"Fejzo","year":"2016","journal-title":"Reprod Toxicol"},{"key":"2020060215103152200_dyz255-B24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200645040-00006","article-title":"Placental transfer of ondansetron during early human pregnancy","volume":"45","author":"Siu","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"2020060215103152200_dyz255-B25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.reprotox.2018.08.018","article-title":"Ondansetron and the teratogenicity in rats: evidence for a mechanism mediated via embryonic hERG blockade","volume":"81","author":"Danielsson","year":"2018","journal-title":"Reprod Toxicol"},{"key":"2020060215103152200_dyz255-B26","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/B978-0-323-40139-5.00050-4","volume-title":"Avery\u2019s Diseases of the Newborn","author":"Dees","year":"2018","edition":"10th edn."},{"key":"2020060215103152200_dyz255-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20740","article-title":"Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment","volume":"20","author":"O\u2019Donnell","year":"2016","journal-title":"Health Technol Assess"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/49\/2\/648\/33338161\/dyz255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/49\/2\/648\/33338161\/dyz255.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T23:25:43Z","timestamp":1612394743000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article\/49\/2\/648\/5682456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,12,20]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/dyz255","relation":{},"ISSN":["0300-5771","1464-3685"],"issn-type":[{"value":"0300-5771","type":"print"},{"value":"1464-3685","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2019,12,20]]}}}